Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas Ciulla, MD
Clearside Biomedical, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Retinal Consultants of Arizona
Phoenix, Arizona, United States
- Retina-Vitreous Associates Medical Group
Beverly Hills, California, United States
- Northern California Retina Vitreous Associates Medical Group, Inc.
Mountain View, California, United States
- Retina Group of Florida
Fort Lauderdale, Florida, United States
- Marietta Eye Clinic
Marietta, Georgia, United States
- Midwest Eye Retina Practicing at Midwest Eye Institute
Indianapolis, Indiana, United States
- Ophthalmic Consultants of Boston
Boston, Massachusetts, United States
- Texas Retina Associates
Dallas, Texas, United States
- Retina Consultants of Houston
Houston, Texas, United States
- Virginia Eye Consultants
Norfolk, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Apr 2017
- Primary completion
- 24 Jan 2018
- Completion
- 24 Jan 2018
- Last update posted
- 23 Jun 2021
- Registered enrollment
- 38
- Registry id
- NCT03097315
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.